NCT02930200 (Smart-T2) is a NA clinical trial of Treatment as Usual in Smoking Cessation, sponsored by University of Oklahoma.

Who is sponsoring NCT02930200?

NCT02930200 is sponsored by University of Oklahoma.

What drugs are being tested in NCT02930200?

Interventions in NCT02930200: Treatment as Usual, QuitGuide, Smart-T.

What condition does NCT02930200 study?

NCT02930200 studies Smoking Cessation.

Is NCT02930200 still recruiting?

NCT02930200 is currently completed. Last updated 20 June 2019.

Last reviewed 2019-06-20 · How we verify

NCT02930200: Smart-T2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Trial of an Automated Smartphone Based Smoking Cessation Treatment

Completed NA Last updated 20 June 2019

What this trial tests

NA trial testing Treatment as Usual in Smoking Cessation in 98 participants. Completed in 1 November 2018.

Timeline

30 May 2017

Primary endpoint
1 November 2018

1 November 2018

Quick facts

Lead sponsor	University of Oklahoma
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	98
Start date	30 May 2017
Primary completion	1 November 2018
Estimated completion	1 November 2018
Sites	1 location across United States

Drugs / interventions tested

Treatment as Usual
QuitGuide
Smart-T

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →

Sponsor

University of Oklahoma

Who can join

18 and older, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary long-term objective of this research is to reduce smoking relapse through the use of automated mobile smoking cessation interventions that tailor content (e.g., treatment messages/materials) in real-time based upon currently present symptoms. The primary short-term objective of this pilot study is to determine the initial utility of a novel smartphone based smoking cessation intervention compared with standard in-person smoking cessation clinic care and the free National Cancer Institute (NCI) QuitGuide smoking cessation application. The current pilot study is a 3 armed randomized clinical trial that aims to determine the initial utility of a novel smartphone based smoking cessation intervention compared with standard in-person smoking cessation clinic care and the free NCI QuitGuide smoking cessation application.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

A Mobile Just-in-Time Adaptive Intervention for Smoking Cessation: Pilot Randomized Controlled Trial.
Hébert ET, Ra CK, Alexander AC, Helt A, et al · · 2020 · cited 93× · PMID 32149716 · DOI 10.2196/16907
Quit Stage and Intervention Type Differences in the Momentary Within-Person Association Between Negative Affect and Smoking Urges.
Benson L, Ra CK, Hébert ET, Kendzor DE, et al · · 2022 · cited 5× · PMID 35425934 · DOI 10.3389/fdgth.2022.864003
Associations between morning affect and later-day smoking urges and behavior.
Benson L, Chen M, De La Torre I, Hébert ET, et al · · 2024 · cited 1× · PMID 38095939 · DOI 10.1037/adb0000970

Verify or expand the search:

Other trials of Treatment as Usual

Trials testing the same drug.

NCT06864715 — Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors · NA · not yet recruiting
NCT06442514 — Pain and Smoking Study - Interactive Voice Response · NA · not yet recruiting
NCT07214233 — Youth Empowerment and Safety Intervention · NA · recruiting
NCT06722027 — CCSH (Compassion-Centered Spiritual Health) for Teams · NA · recruiting
NCT07108608 — Adaptation of Written Exposure Therapy in Substance Treatment · NA · not yet recruiting

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Other University of Oklahoma trials

Trials by the same sponsor.

NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
NCT07494773 — Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection · Phase 1, PHASE2 · not yet recruiting
NCT07014605 — Smoking Cessation Program for Lao People With HIV · NA · not yet recruiting
NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07491653 — Fiber mHealth Intervention for Prediabetes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02930200 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oklahoma
Last refreshed: 20 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02930200.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing